Granulocyte colony-stimulating factor priming improves egg and embryo quality in patients with poor ovarian reserve: a retrospective case study
Xianghui Zeng,Zhongzhen Liang,Fang Wang
DOI: https://doi.org/10.21203/rs.3.rs-3997062/v1
2024-01-01
Abstract:Abstract Background Granulocyte colony-stimulating factor (G-CSF) administration increased ovarian preantral follicles in animal models with diminished ovarian reserve. We retrospectively investigated whether G-CSF priming on superovulation initiation day with assisted reproductive technology (ART) improved egg maturation and embryonic development in patients with poor ovarian reserve. Methods In this retrospective clinical case study, 174 patients aged 20 to 45 years were divided into a test group(40 patients each) and a control group (134 patients each) based on whether or not they used G-CSF. All patients in the priming group but not the control group received subcutaneous G-CSF priming injection on superovulation initiation day. Then, each group underwent 1 cycle of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), because all groups adopted PPOS protocol, which required freezing of all transferable embryos, and thawing embryos for transfer. Results Before propensity score matching, there were statistically significant differences in number of 2PN(6.4 ± 3.74 vs4.3 ± 2.44, P = 0.001), number of eggs retrievals(8.3 ± 4.16 vs 6.0 ± 3.26,P = 0.003), number of total fertilization(7.1 ± 3.69 vs 4.8 ± 2.54,P = 0), number of transferable embryos(6.6 ± 3.74 vs 4.3 ± 2.39,P = 0) and number of cleavage(7.1 ± 3.75 vs 4.6 ± 2.44,P = 0) were significantly improved by priming. After the propensity score matching(1:1),There were statistically significant differences in number of MII (4.9 ± 5.15 vs 6.4 ± 2.77 P = 0).The number of 2PN (5.9 ± 3.55 vs 4.6 ± 2.22,P = 0.1), number of eggs retrievals(7.9 ± 4.17 vs 6.6 ± 2.77,P = 0.3), number of total fertilization(6.9 ± 3.57 vs 5.3 ± 2.39, P = 0.1), number of transferable embryos(6.3 ± 3.58 vs 4.8 ± 1.92,P = 0.1) and number of cleavage(6.8 ± 3.64 vs 5.1 ± 2.24,P = 0.1) tended to be higher in 33 G-CSF patients than in 33 controls, although statistical significance was not attained respectively. After matching propensity scores(1:2),there were statistically significant differences in number of transferable embryos(6.4 ± 3.62 vs 4.8 ± 2.49,P = 0.045), were significantly improved by priming. The number of 2PN (5.9 ± 3.60 vs 4.8 ± 2.77, P = 0.17), number of eggs retrievals (8.0 ± 4.30 vs 6.9 ± 3.64, P = 0.285), number of total fertilization (6.9 ± 3.64 vs 5.5 ± 2.84, P = 0.087), and number of cleavage (6.8 ± 3.71 vs 5.3 ± 2.73, P = 0.08) tended to be higher in 31 G-CSF patients than in 52 controls, although statistical significance was not attained respectively. In addition, the G-CSF patients achieved more cryopreservation of transplantable embryos than the control group. Conclusion The administration of G-CSF during Superovulation day of ART cycle can improve embryonic development potential of patients with poor ovarian reserve, with a view to improving future clinical pregnancy rates and live birth rates.